JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2012, 61(5):234-239

Methods of pharmaceutical technology in preparation of pellets for detection of acetylcholinesterase inhibitors

David Vetchý1,*, Hana Leštinová2, Ivana Tušarová3
1 Ústav technologie léků, Farmaceutická fakulta, Veterinární a farmaceutická univerzita, Brno
2 Lékárna Na Předměstí, Třeboň
3 Oritest spol s r.o., Praha

A variety of methods and technical equipment are currently available for checking of air contaminants. Generally, all known and sophisticated methods are based on sampling of substances in the air using different collectors or their capture in a suitable medium. However, new detection methods particularly useful in outdoor conditions are still looking for. Detection systems must be transportable, fast acting, inexpensive, sensitive and selective, and their operation should not be complicated. Such an appropriate system for the detection of carbamates and highly toxic organophosphates is detection tubes with microcrystalline cellulose pellets containing immobilized acetylcholinesterase, by which analyzed air is sucked through. The detection is based on the colorimetric Ellman reaction. Experimental work deals with the use of pharmaceutical technology methods for preparation of new variants of pellets for the detection of acetylcholinesterase inhibitors with 20% and 50% content of inorganic fillers (aluminium oxide, kaolin, colloidal silica, nalsit) produced by extrusion / spheronization. Pellets were impregnated by acetylcholinesterase after evaluating quality parameters and were tested for their activity and inhibition with Ellman's reagent. Pellets without inorganic fillers, containing 50% of aluminium oxide and containing 20% of colloidal silica were evaluated as a suitable filling of detection tubes.

Keywords: pellets; extrusion, spheronization; inorganic fillers; acetylcholinesterase inhibitors; detection tubes

Received: September 4, 2012; Accepted: September 18, 2012; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vetchý D, Leštinová H, Tušarová I. Methods of pharmaceutical technology in preparation of pellets for detection of acetylcholinesterase inhibitors. Čes. slov. farm. 2012;61(5):234-239.
Download citation

References

  1. Pitschmann V., Halámek E., Kobliha Z., Tušarová I. Výzkum detekčních trubiček pro bojové chemické látky v České republice. Chem. Listy 2011; 105, 334-345.
  2. Pitschmann V. Analýza toxických látek detekčními trubičkami. 2. vyd. Drahelčice: Econt Consulting 2005; 194 s.
  3. Halámek E., Kobliha Z., Pitschmann V. Analýza bojových chemických látek. 1. vyd. Vyškov: Univerzita obrany Brno, Ústav ochrany proti zbraním hromadného ničení 2007; 155 s.
  4. Žďárová-Karasová J., Kuča K., Jun D., Bajgar J. Užití Ellmanovy metody pro stanovení aktivit cholinesteras při in vivo hodnocení účinků reaktivátorů. Chem. Listy 2010; 104, 46-50.
  5. Hasznos L., Langer I., Gyamathy M. Some factors influencing pellet characteristics made by an extrusion/spheronisation process Part I.: Effects on size characteristics and moisture content decrease of pellets. Drug Dev. Ind. Pharm. 1992; 18, 409-412. Go to original source...
  6. Kolektiv autorů: Český lékopis 2009, Praha: Grada Publishing 2009.
  7. Sienkiewicz G., Pereira R., Rudnic E. M. Spheronization of theophylline-avicel combinations using a fluidized-bed rotogranulation technique. Drug Dev. Ind. Pharm. 1997; 23, 173-177. Go to original source...
  8. Krejčová K., Rabišková M., Vetchý D., Polášek E., Tomášek V., Prokopová A. The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor. Drug Dev. Ind. Pharm. 2006; 32, 585-593. Go to original source... Go to PubMed...
  9. Thommes M., Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/ spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm. 2006; 63, 59-67. Go to original source... Go to PubMed...
  10. Ghanam D., Hassan I., Kleinebudde P. Compression behaviour of kappa-carrageenan pellets. Int. J. Pharm. 2010; 390, 117-127. Go to original source... Go to PubMed...
  11. Deasy P. B., Law M. F. L. Use of extrusion-spheronization to develop an improved oral dosage form of indometacin. Int. J. Pharm. 1997; 148, 201-209. Go to original source...
  12. Law M. F. L., Deasy P. B. Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion-spheronization. Eur. J. Pharm. Biopharm. 1998; 45, 57-65. Go to original source... Go to PubMed...
  13. Sousa J. J., Sousa A., Podczeck F., Newton J. M. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int. J. Pharm. 2002; 232, 91-106. Go to original source... Go to PubMed...
  14. Costa F. O., Pais A. A. C. C., Sousa J. J. S. Analysis of formulation effects in the dissolution of ibuprofen pellets. Int. J. Pharm. 2004; 270, 9-19. Go to original source... Go to PubMed...
  15. Vertommen J., Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug Dev. Ind. Pharm. 1997; 23, 39-46. Go to original source...
  16. http://www.oritest-group.com (14. 8. 2012)




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.